HKD 1.64
(1.86%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 259.85 Million USD | 3.79% |
2022 | 250.36 Million USD | 35.74% |
2021 | 184.44 Million USD | 46.6% |
2020 | 125.81 Million USD | 25.29% |
2019 | 100.41 Million USD | 20.82% |
2018 | 83.11 Million USD | 18.32% |
2017 | 70.24 Million USD | 44.41% |
2016 | 48.64 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 128.47 Million USD | 0.0% |
2023 Q4 | 131.49 Million USD | 0.0% |
2023 Q2 | 128.35 Million USD | 0.0% |
2023 FY | 259.85 Million USD | 3.79% |
2022 FY | 250.36 Million USD | 35.74% |
2022 Q2 | 118.93 Million USD | 0.0% |
2022 Q4 | 131.42 Million USD | 0.0% |
2021 Q2 | 85.12 Million USD | 0.0% |
2021 FY | 184.44 Million USD | 46.6% |
2021 Q4 | 99.31 Million USD | 0.0% |
2020 Q4 | 75.15 Million USD | 0.0% |
2020 Q2 | 50.65 Million USD | 0.0% |
2020 FY | 125.81 Million USD | 25.29% |
2019 Q4 | 50.72 Million USD | 0.0% |
2019 FY | 100.41 Million USD | 20.82% |
2019 Q2 | 49.68 Million USD | 0.0% |
2018 Q2 | 37.08 Million USD | 0.0% |
2018 Q4 | 46.02 Million USD | 0.0% |
2018 FY | 83.11 Million USD | 18.32% |
2017 Q1 | 17.56 Million USD | 0.0% |
2017 FY | 70.24 Million USD | 44.41% |
2017 Q4 | 20.77 Million USD | 0.0% |
2017 Q2 | 17.56 Million USD | 0.0% |
2016 Q4 | 17.56 Million USD | 0.0% |
2016 FY | 48.64 Million USD | 0.0% |
2016 Q1 | 12.16 Million USD | 0.0% |
2016 Q2 | 12.16 Million USD | 0.0% |
2015 Q4 | 12.16 Million USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Uni-Bio Science Group Limited | 484.71 Million HKD | 46.39% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.32 Billion HKD | 95.118% |